Article Details
Retrieved on: 2024-02-08 16:48:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Latozinemab is an investigational human monoclonal antibody. · The drug is currently being examined in a phase 3 clinical trial.
Article found on: www.healio.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here